Keywords: naratriptan, launched, usa, glaxo, wellcome, its, 5-ht1b/1d

Naratriptan Launched In The USA

Article | 26 March 1998

Print This

Glaxo Wellcome has launched its 5-HT1B/1D agonist Amerge (naratriptan)in 1mg and 2.5mg tablet form in the USA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in